Stryker Blade Recall To Be Complete By September; OP-1 PMA Filed By FDA
This article was originally published in The Gray Sheet
Executive Summary
Stryker Instruments anticipates retrieving within 30 days certain lots of Heavy Duty blades recalled because of a "slight potential" for package failure that could affect the sterility of the devices.
You may also be interested in...
Stryker Management Trio Poised To Restore 20% Earnings Growth By 2000
Stryker's ability to successfully integrate Howmedica and return to historical earnings growth (20% annually the past two decades) by 2000 rests largely in the hands of three recently appointed Group Presidents - Ronald A. Elenbaas (Med-Surg), Edward "Ned" Lipes (Howmedica Osteonics U.S.) and Jack O'Mahony (Stryker International).
Stryker
Completes acquisition of Pfizer's Howmedica orthopedic division for $1.65 bil. in cash, the firms report Dec. 4. The deal was first announced in August ("The Gray Sheet" Aug. 17, p. 3)
Keeping Track: Submissions Galore Start The New Year; US FDA Clears New Indications For Enhertu, Xalkori
The latest drug development news and highlights from the Pink Sheet US FDA Performance Tracker
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: